Dupixent
Dupilumab · Sanofi-Aventis U.S. LLC
PRESCRIPTION ONLY (USA)Dupixent ingredients
| Active ingredient | Strength |
|---|---|
| Dupilumab | 200 mg/1.14mL, 300 mg/2mL |
What Dupixent is used for
Dupixent is a specialist medicine (interleukin-4 receptor alpha antagonist). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Dupixent
- Generic name
- Dupilumab
- Made by
- Sanofi-Aventis U.S. LLC
- Forms
- Injection, Solution
- Given
- Subcutaneous
- Drug class
- Interleukin-4 Receptor alpha Antagonist
- FDA approval
- Biologic licence (BLA) BLA761055
- On the US market since
- 2017
Official information
- Dupixent prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Dupilumab)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Dupixent?
Dupixent (Dupilumab) is a specialist medicine made by Sanofi-Aventis U.S. LLC, approved by the US FDA.
What are the ingredients of Dupixent?
Dupixent contains Dupilumab (200 mg/1.14mL, 300 mg/2mL).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA